Needs Statement

The opioid use epidemic has been on the forefront of societal concerns in the US. With the DEA-MATE act, all providers have to be able to adeptly prescribe and manage Opioid Use Disorder and related issues, which have proliferated. Treating teams face multiple challenges including need to treat chronic pain, overprescription of opioids and need for effective alternatives, and illicit use of opioids. The focus of this conference is pharmacological, psychotherapeutic treatments of OUD along with overviews of impact on families and children. We are proud to involve multiple community organizations that provide substance use  treatments so attendees can have a comprehensive view of how to get patients effective OUD treatments in and out of the medical system. A main goal for the attendees is to be empowered and confident to initiate and/or maintain treatments for OUD.

Course Director

Nidal Moukaddam, MD, PhD, Professor, Baylor College of Medicine, Psychiatry & Behavioral Sciences - nidalm@bcm.edu

Andres Ojeda, MD, Associate Professor, Baylor College for Medicine, Psychiatry & Behavioral Sciences - aaojeda@bcm.edu

TARGET AUDIENCE

This activity is intended for physicians and advanced-practice providers in psychiatry, emergency medicine, family medicine, internal medicine, and obstetrics and gynecology and the community.

EDUCATIONAL OBJECTIVES

At the conclusion of this activity, the participant should be able to:

• Apply treatment techniques, including pharmacologic and psychotherapeutic approaches, in managing Opioid Use Disorder.
• Identify the health disparities and ethical challenges that impact diverse LGBTQ communities in the treatment of Opioid Use Disorders.
• Recognize barriers to accessing medication in treatment of Opioid Use Disorder treatment.
• Identify and appropriately respond to signs and symptoms of opioid use disorder and opioid withdrawal.
• Recall and apply person-first language, emphasizing the individual rather than the diagnosis, when interacting with patients diagnosed with Opioid Use Disorder.
• Identify the ethical implications of implementing interdisciplinary and community-engaged approaches to address opioid use disorder within marginalized populations.
• Discuss the ethical considerations of substance use during pregnancy, including prevalence, associated risks, and considerations for patient care and provider responsibilities.

EDUCATIONAL METHODS

Lecture, Case Study, Small Group Breakout Session, Qualtrics Survey and Other

EVALUATION

Evaluation by questionnaire will address program content, presentation, and possible bias.

Acknowledgement of Support

This CME activity is supported by an educational grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) grant 1H79FG001068-01.